United Kingdom · Question · Written question
UIN 156075
Medicines and Healthcare products Regulatory Agency: Clinical Trials
Introduced
1 March 2023
Last action
10 March 2023 · Answer
Status
Answered
Sponsors
—
Subjects
Healthcare
Source updated
10 March 2023
Summary
To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the overall effectiveness of the MHRA in supporting and evaluating clinical trials in the UK; and what assessment he has made of the potential future risk
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
1 March 2023
Written question
To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the overall effectiveness of the MHRA in supporting and evaluating clinical trials in the UK; and what assessment he has made of the potential future risk
Source: Commons
10 March 2023
Answer
The Medicines and Healthcare products Regulatory Agency (MHRA) recently underwent a programme organisational reform and transformation, supported by independent advisors, to deliver an agency able to modernise medicines and medical device regulation in th...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2023-03-01/156075
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1600427
- uk · wq-1600427 · source updated 10 March 2023